Leishmania amazonensis from distinct clinical forms/hosts has polymorphisms in Lipophosphoglycans, displays variations in immunomodulatory properties and, susceptibility to antileishmanial drugs.
Cell Biol Int
; 46(11): 1947-1958, 2022 Nov.
Article
en En
| MEDLINE
| ID: mdl-35998255
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Anfotericina B
/
Leishmania
Límite:
Animals
Idioma:
En
Año:
2022
Tipo del documento:
Article